Cargando…

A Case of Persistent Hyperinsulinemic Hypoglycemia of Infancy Successfully Managed with Subcutaneous Octreotide Injection and Nocturnal Intravenous Glucose Supply

Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is often resistant to medical therapy and is normally treated by subtotal pancreatectomy to avoid neurological complications. However, many problems after surgery, such as recurrence of hypoglycemia and diabetes mellitus, remain to be solved...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Mari, Mushiake, Sotaro, Kashiwagi, Hiroko, Etani, Yuri, Miyoshi, Yoko, Ozono, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004892/
https://www.ncbi.nlm.nih.gov/pubmed/24790349
http://dx.doi.org/10.1297/cpe.16.75
_version_ 1782314029606240256
author Murakami, Mari
Mushiake, Sotaro
Kashiwagi, Hiroko
Etani, Yuri
Miyoshi, Yoko
Ozono, Keiichi
author_facet Murakami, Mari
Mushiake, Sotaro
Kashiwagi, Hiroko
Etani, Yuri
Miyoshi, Yoko
Ozono, Keiichi
author_sort Murakami, Mari
collection PubMed
description Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is often resistant to medical therapy and is normally treated by subtotal pancreatectomy to avoid neurological complications. However, many problems after surgery, such as recurrence of hypoglycemia and diabetes mellitus, remain to be solved. This report concerns a case of PHHI that was resistant to octreotide or diazoxide alone but was successfully controlled with subcutaneous injection of octreotide in combination with nocturnal glucose infusion through central venous catheter. The patient exhibited natural remission of hyperinsulinism with age, and all treatment was ceased at the age of 4 yr. Growth and neurological development of the patient have been normal. This combined therapy can be a therapeutic option as a substitute for surgical solutions.
format Online
Article
Text
id pubmed-4004892
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher The Japanese Society for Pediatric Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-40048922014-04-30 A Case of Persistent Hyperinsulinemic Hypoglycemia of Infancy Successfully Managed with Subcutaneous Octreotide Injection and Nocturnal Intravenous Glucose Supply Murakami, Mari Mushiake, Sotaro Kashiwagi, Hiroko Etani, Yuri Miyoshi, Yoko Ozono, Keiichi Clin Pediatr Endocrinol Original Article Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is often resistant to medical therapy and is normally treated by subtotal pancreatectomy to avoid neurological complications. However, many problems after surgery, such as recurrence of hypoglycemia and diabetes mellitus, remain to be solved. This report concerns a case of PHHI that was resistant to octreotide or diazoxide alone but was successfully controlled with subcutaneous injection of octreotide in combination with nocturnal glucose infusion through central venous catheter. The patient exhibited natural remission of hyperinsulinism with age, and all treatment was ceased at the age of 4 yr. Growth and neurological development of the patient have been normal. This combined therapy can be a therapeutic option as a substitute for surgical solutions. The Japanese Society for Pediatric Endocrinology 2007-08-08 2007 /pmc/articles/PMC4004892/ /pubmed/24790349 http://dx.doi.org/10.1297/cpe.16.75 Text en 2007©The Japanese Society for Pediatric Endocrinology http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License.
spellingShingle Original Article
Murakami, Mari
Mushiake, Sotaro
Kashiwagi, Hiroko
Etani, Yuri
Miyoshi, Yoko
Ozono, Keiichi
A Case of Persistent Hyperinsulinemic Hypoglycemia of Infancy Successfully Managed with Subcutaneous Octreotide Injection and Nocturnal Intravenous Glucose Supply
title A Case of Persistent Hyperinsulinemic Hypoglycemia of Infancy Successfully Managed with Subcutaneous Octreotide Injection and Nocturnal Intravenous Glucose Supply
title_full A Case of Persistent Hyperinsulinemic Hypoglycemia of Infancy Successfully Managed with Subcutaneous Octreotide Injection and Nocturnal Intravenous Glucose Supply
title_fullStr A Case of Persistent Hyperinsulinemic Hypoglycemia of Infancy Successfully Managed with Subcutaneous Octreotide Injection and Nocturnal Intravenous Glucose Supply
title_full_unstemmed A Case of Persistent Hyperinsulinemic Hypoglycemia of Infancy Successfully Managed with Subcutaneous Octreotide Injection and Nocturnal Intravenous Glucose Supply
title_short A Case of Persistent Hyperinsulinemic Hypoglycemia of Infancy Successfully Managed with Subcutaneous Octreotide Injection and Nocturnal Intravenous Glucose Supply
title_sort case of persistent hyperinsulinemic hypoglycemia of infancy successfully managed with subcutaneous octreotide injection and nocturnal intravenous glucose supply
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004892/
https://www.ncbi.nlm.nih.gov/pubmed/24790349
http://dx.doi.org/10.1297/cpe.16.75
work_keys_str_mv AT murakamimari acaseofpersistenthyperinsulinemichypoglycemiaofinfancysuccessfullymanagedwithsubcutaneousoctreotideinjectionandnocturnalintravenousglucosesupply
AT mushiakesotaro acaseofpersistenthyperinsulinemichypoglycemiaofinfancysuccessfullymanagedwithsubcutaneousoctreotideinjectionandnocturnalintravenousglucosesupply
AT kashiwagihiroko acaseofpersistenthyperinsulinemichypoglycemiaofinfancysuccessfullymanagedwithsubcutaneousoctreotideinjectionandnocturnalintravenousglucosesupply
AT etaniyuri acaseofpersistenthyperinsulinemichypoglycemiaofinfancysuccessfullymanagedwithsubcutaneousoctreotideinjectionandnocturnalintravenousglucosesupply
AT miyoshiyoko acaseofpersistenthyperinsulinemichypoglycemiaofinfancysuccessfullymanagedwithsubcutaneousoctreotideinjectionandnocturnalintravenousglucosesupply
AT ozonokeiichi acaseofpersistenthyperinsulinemichypoglycemiaofinfancysuccessfullymanagedwithsubcutaneousoctreotideinjectionandnocturnalintravenousglucosesupply
AT murakamimari caseofpersistenthyperinsulinemichypoglycemiaofinfancysuccessfullymanagedwithsubcutaneousoctreotideinjectionandnocturnalintravenousglucosesupply
AT mushiakesotaro caseofpersistenthyperinsulinemichypoglycemiaofinfancysuccessfullymanagedwithsubcutaneousoctreotideinjectionandnocturnalintravenousglucosesupply
AT kashiwagihiroko caseofpersistenthyperinsulinemichypoglycemiaofinfancysuccessfullymanagedwithsubcutaneousoctreotideinjectionandnocturnalintravenousglucosesupply
AT etaniyuri caseofpersistenthyperinsulinemichypoglycemiaofinfancysuccessfullymanagedwithsubcutaneousoctreotideinjectionandnocturnalintravenousglucosesupply
AT miyoshiyoko caseofpersistenthyperinsulinemichypoglycemiaofinfancysuccessfullymanagedwithsubcutaneousoctreotideinjectionandnocturnalintravenousglucosesupply
AT ozonokeiichi caseofpersistenthyperinsulinemichypoglycemiaofinfancysuccessfullymanagedwithsubcutaneousoctreotideinjectionandnocturnalintravenousglucosesupply